136 related articles for article (PubMed ID: 10666475)
1. Functional coexpression of serine protein kinase SRPK1 and its substrate ASF/SF2 in Escherichia coli.
Yue BG; Ajuh P; Akusjärvi G; Lamond AI; Kreivi JP
Nucleic Acids Res; 2000 Mar; 28(5):E14. PubMed ID: 10666475
[TBL] [Abstract][Full Text] [Related]
2. The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs).
Koizumi J; Okamoto Y; Onogi H; Mayeda A; Krainer AR; Hagiwara M
J Biol Chem; 1999 Apr; 274(16):11125-31. PubMed ID: 10196197
[TBL] [Abstract][Full Text] [Related]
3. Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies.
Chandra A; Goyal N; Qamar I; Singh N
J Biomol Struct Dyn; 2021 Mar; 39(5):1579-1587. PubMed ID: 32093544
[TBL] [Abstract][Full Text] [Related]
4. A novel Physarum polycephalum SR protein kinase specifically phosphorylates the RS domain of the human SR protein, ASF/SF2.
Liu S; Kang K; Zhang J; Ouyang Q; Zhou Z; Tian S; Xing M
Acta Biochim Biophys Sin (Shanghai); 2009 Aug; 41(8):657-67. PubMed ID: 19657567
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
Xiao SH; Manley JL
Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.
Labourier E; Rossi F; Gallouzi IE; Allemand E; Divita G; Tazi J
Nucleic Acids Res; 1998 Jun; 26(12):2955-62. PubMed ID: 9611241
[TBL] [Abstract][Full Text] [Related]
7. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.
Colwill K; Feng LL; Yeakley JM; Gish GD; Cáceres JF; Pawson T; Fu XD
J Biol Chem; 1996 Oct; 271(40):24569-75. PubMed ID: 8798720
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.
Ma CT; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2010 Oct; 403(3):386-404. PubMed ID: 20826166
[TBL] [Abstract][Full Text] [Related]
9. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
10. Processive phosphorylation of alternative splicing factor/splicing factor 2.
Aubol BE; Chakrabarti S; Ngo J; Shaffer J; Nolen B; Fu XD; Ghosh G; Adams JA
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12601-6. PubMed ID: 14555757
[TBL] [Abstract][Full Text] [Related]
11. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.
Ngo JC; Chakrabarti S; Ding JH; Velazquez-Dones A; Nolen B; Aubol BE; Adams JA; Fu XD; Ghosh G
Mol Cell; 2005 Oct; 20(1):77-89. PubMed ID: 16209947
[TBL] [Abstract][Full Text] [Related]
12. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
Cao W; Garcia-Blanco MA
J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
[TBL] [Abstract][Full Text] [Related]
13. Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1.
Hagopian JC; Ma CT; Meade BR; Albuquerque CP; Ngo JC; Ghosh G; Jennings PA; Fu XD; Adams JA
J Mol Biol; 2008 Oct; 382(4):894-909. PubMed ID: 18687337
[TBL] [Abstract][Full Text] [Related]
14. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
15. Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1.
Ma CT; Hagopian JC; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2009 Jul; 390(4):618-34. PubMed ID: 19477182
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors.
Gui JF; Tronchère H; Chandler SD; Fu XD
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10824-8. PubMed ID: 7526381
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty.
Velazquez-Dones A; Hagopian JC; Ma CT; Zhong XY; Zhou H; Ghosh G; Fu XD; Adams JA
J Biol Chem; 2005 Dec; 280(50):41761-8. PubMed ID: 16223727
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression.
Chandra A; Ananda H; Singh N; Qamar I
Aging (Albany NY); 2020 Dec; 13(1):163-180. PubMed ID: 33291073
[TBL] [Abstract][Full Text] [Related]
19. Allosteric interactions direct binding and phosphorylation of ASF/SF2 by SRPK1.
Huynh N; Ma CT; Giang N; Hagopian J; Ngo J; Adams J; Ghosh G
Biochemistry; 2009 Dec; 48(48):11432-40. PubMed ID: 19886675
[TBL] [Abstract][Full Text] [Related]
20. The splicing-factor oncoprotein SF2/ASF activates mTORC1.
Karni R; Hippo Y; Lowe SW; Krainer AR
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15323-7. PubMed ID: 18832178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]